Expired activity
Please go to the PowerPak homepage and select a course.

Immunooncology and Targeted Therapy Combinations for Advanced Renal Cell Carcinoma: Pharmacist Focus on Managing the Patient (Recorded Podcast)

acpeA Patient Perspectives Presentation

» References (PDF)

FACULTY

Lisa Holle, PharmD, BCOP, FHOPA, FISOPP
Clinical Professor
University of Connecticut
School of Pharmacy and School of Medicine
UConn Health Carole and Ray Neag Comprehensive Cancer Center

LEARNING OBJECTIVES

Upon completion of this program, participants should be better able to:

  • Discuss the rational and efficacy of current immune checkpoint inhibitor (ICI) and targeted therapy combinations utilized in the treatment strategies for advanced renal cell carcinoma (RCC)
  • Identify methods for optimal management of patients on combination therapies for advanced RCC including toxicities, adherence, medication education and financial assistance

Click here to Show/Hide Audio

Back to Top